Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response

Gastroenterology
Sanaa M KamalNezam H Afdhal

Abstract

Pegylated interferon therapy has not been adequately evaluated in acute hepatitis C virus (HCV) infection. This randomized trial assessed the efficacy, safety, and timing of pegylated interferon alfa-2b for treatment of acute hepatitis C. One hundred seventy-five patients acutely infected with HCV were screened. Patients whose infection did not spontaneously resolve by week 8 were randomized to once weekly peginterferon alfa-2b monotherapy (1.5 microg/kg per week) started at weeks 8, 12, or 20 for a duration of 12 weeks. The primary endpoint was undetectable HCV RNA 24 weeks after the end of treatment (sustained virologic response [SVR]). All patients were followed for 48 weeks after cessation of therapy. One hundred twenty-nine subjects started treatment at week 8 (group A, n = 43), week 12 (group B, n = 43), or week 20 (group C, n = 43). By using an intent-to-treat analysis, the overall SVR rate was 87%. The SVR rates were 95%, 92%, and 76% with treatment onset at 8, 12, and 20 weeks, respectively. Overall, SVR rates were better for patients infected with genotypes 2, 3, and 4 than those infected with genotype 1. Earlier initiation of therapy improved SVR rates for patients infected with genotype 1 with high viral load. Pegin...Continue Reading

Citations

Jun 2, 2012·Epidemiology and Infection·R Sacks-DavisM Hellard
Feb 5, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G V MatthewsUNKNOWN Australian Trial in Acute Hepatitis C Study Group
Nov 23, 2007·Journal of Clinical Microbiology·Kimberly Page-ShaferMichael P Busch
Oct 4, 2012·Virology Journal·Mohammed AsmalRalf Geiben-Lynn
Mar 6, 2012·Virology Journal·Wosen AmanShaker A Mousa
Apr 19, 2012·PloS One·Nicolas DurierLisa J White
Oct 4, 2012·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Abdullah S AlghamdiUNKNOWN Saudi Association for the Study of Liver Diseases and Transplantation
Mar 14, 2013·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Melanie DeutschJohn Koskinas
Mar 15, 2014·Biochemia Medica·Gabriella De CarliVincenzo Puro
Apr 6, 2016·Clinical and Molecular Hepatology·UNKNOWN Korean Association for the Study of the Liver
Apr 18, 2012·Scandinavian Journal of Infectious Diseases·Martin LaggingUNKNOWN Swedish Consensus Group
Sep 29, 2007·The American Journal of Gastroenterology·Sanaa M Kamal
Dec 29, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jason T BlackardKenneth E Sherman
Aug 19, 2008·Journal of Hepatology·Teresa SantantonioJ Tilman Gerlach
Jan 12, 2010·HIV Medicine·G BrookUNKNOWN BHIVA Viral Hepatitis Working Group
Feb 18, 2014·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·E Kainne DokuboKimberly Page
Mar 23, 2011·Nature Reviews. Gastroenterology & Hepatology·Jason GrebelyGregory J Dore
Apr 22, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sanaa M KamalNezam H Afdhal
Mar 31, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marc G GhanyUNKNOWN American Association for the Study of Liver Diseases
Dec 26, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gary P JeffreyGeorge O'Neil
Sep 29, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Heiner WedemeyerMichael Manns
Nov 11, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lionel PirothUNKNOWN Steering Committee of the HEPAIG Study
Jun 25, 2009·European Journal of Gastroenterology & Hepatology·Charalabos-Markos DintsiosChristian Krauth
Sep 8, 2009·European Journal of Gastroenterology & Hepatology·Thierry MorinUNKNOWN Association Nationale des Hépato-gastroentérologues des Hôpitaux généraux (ANGH) Société de Pathologie Infectieuse de Langue
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Jeffrey D KingsleyChristopher J Destache
May 15, 2008·The American Journal of Gastroenterology·Sanaa M Kamal
Apr 7, 2007·Current Opinion in Gastroenterology·Jessica Tan, Anna Sf Lok
Aug 14, 2009·Journal of Viral Hepatitis·K E CoreyR T Chung
Apr 23, 2010·Digestive Diseases and Sciences·Javid FaziliCharles L Lackey
May 19, 2010·Digestive Diseases and Sciences·Carmi Santos, Steven K Herrine
Aug 31, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jason GrebelyUNKNOWN ATAHC Study Group
Jan 5, 2008·Oral Diseases·A A Modi, T J Liang
Apr 21, 2007·Journal of Gastroenterology and Hepatology·UNKNOWN Asian Pacific Association for the Study of the Liver (APASL) Hepatitis C Working PartyR Tateishi
Feb 20, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H-X WuUNKNOWN Enhanced Hepatitis Strain Surveillance System (c/o Ms. Marlene Huard, Executive Assistant)
Feb 12, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Sanaa M Kamal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.